Insider Transactions in Q2 2022 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2022
|
Giovanni Caforio Executive Chair of the Board |
SELL
Open market or private sale
|
Direct |
30,000
-5.16%
|
$2,220,000
$74.04 P/Share
|
|
Jun 06
2022
|
Sandra Leung EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
65,000
-17.4%
|
$4,810,000
$74.89 P/Share
|
|
Jun 03
2022
|
Julia A Haller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,949
+17.8%
|
-
|
|
Apr 01
2022
|
Elizabeth Mily EVP, Strategy & BD |
SELL
Payment of exercise price or tax liability
|
Direct |
3,333
-13.71%
|
$243,309
$73.82 P/Share
|
|
Apr 01
2022
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Exercise of conversion of derivative security
|
Direct |
6,347
+21.8%
|
-
|
|
Apr 01
2022
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Other acquisition or disposition
|
Direct |
1,508
+11.17%
|
-
|